Research & Development
Incyte receives positive CHMP opinion for Minjuvi in relapsed or refractory follicular lymphoma
17 November 2025 - Biopharmaceutical company Incyte (Nasdaq:INCY) announced on Monday that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a posit...
Henlius and Organon secure first US approval for pertuzumab biosimilar POHERDY
17 November 2025 - China-based biopharmaceutical company Shanghai Henlius Biotech Inc (HK:2696) and US healthcare company Organon (NYSE:OGN) announced on Monday that the US Food and Drug Administratio...
BioInvent secures EMA positive opinion for Orphan Drug Designation of BI-1808 in CTCL
17 November 2025 - Swedish biotech company BioInvent International AB (STO:BINV) announced on Monday that the European Medicines Agency's Committee for Orphan Medicinal Products has issued a posi...
Lupin launches Risperidone long-acting injectable with 180-day CGT exclusivity in US market
17 November 2025 - India-based global pharma company Lupin Limited (BSE: 500257) (NSE: LUPIN) announced on Friday the US launch of Risperidone for extended-release injectable suspension, 25 mg per via...
BodyLogicMD supports recommendation to remove black box warnings on certain forms of oestrogen
17 November 2025 - BodyLogicMD, a provider of bioidentical hormone replacement therapy (BHRT), integrative medicine and weight loss treatment, said on Friday that it completely supports the recommenda...
Fondazione Telethon reports positive opinion for Waskyra marketing authorisation in Europe
17 November 2025 - Fondazione Telethon, an Italy-based non-profit biomedical organisation, announced on Friday that it has received positive opinion from the European Medicines Agency's (EMA) Com...